These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 36161280)
21. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma. Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908 [TBL] [Abstract][Full Text] [Related]
22. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients. Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460 [TBL] [Abstract][Full Text] [Related]
23. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer. Wu T; Li S; Yu C; Wu Y; Long H Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838 [TBL] [Abstract][Full Text] [Related]
24. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma. Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H Front Immunol; 2023; 14():1111494. PubMed ID: 36817451 [TBL] [Abstract][Full Text] [Related]
25. Identification of a pyroptosis-related prognosis gene signature and its relationship with an immune microenvironment in gliomas. Xiao S; Yan Z; Zeng F; Lu Y; Qiu J; Zhu X Medicine (Baltimore); 2022 Jul; 101(28):e29391. PubMed ID: 35839032 [TBL] [Abstract][Full Text] [Related]
26. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. Chen Z; Zhang W; Yan Z; Zhang M Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574 [TBL] [Abstract][Full Text] [Related]
28. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. Huang Q; Li J; Mo L; Zhao Y World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369 [TBL] [Abstract][Full Text] [Related]
29. Identification of a pyroptosis-related prognostic signature in breast cancer. Chen H; Luo H; Wang J; Li J; Jiang Y BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas. Zhou Z; Wei J; Lu B; Jiang W; Bao Y; Li L; Wang W Front Genet; 2021; 12():763807. PubMed ID: 35198000 [No Abstract] [Full Text] [Related]
31. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
32. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas. Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200 [TBL] [Abstract][Full Text] [Related]
33. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis. Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W Front Immunol; 2021; 12():557994. PubMed ID: 34220791 [TBL] [Abstract][Full Text] [Related]
34. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
35. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma. Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304 [TBL] [Abstract][Full Text] [Related]
36. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes. Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452 [TBL] [Abstract][Full Text] [Related]
37. A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma. Fan W; Wang D; Li G; Xu J; Ren C; Sun Z; Wang Z; Ma W; Zhao Z; Bao Z; Jiang T; Zhang Y CNS Neurosci Ther; 2022 Dec; 28(12):2090-2103. PubMed ID: 35985661 [TBL] [Abstract][Full Text] [Related]
38. Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma. He Y; Cai Y; Liu J; Ding H; Li X; Tian S; Li Z Cells; 2022 Dec; 11(24):. PubMed ID: 36552744 [TBL] [Abstract][Full Text] [Related]
39. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics. Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J PeerJ; 2023; 11():e16631. PubMed ID: 38144182 [TBL] [Abstract][Full Text] [Related]
40. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma. Liu H; Tao T Front Oncol; 2022; 12():1015850. PubMed ID: 36605437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]